Photodynamic therapy with 3‐(1′‐hexyloxyethyl) pyropheophorbide‐a for early‐stage cancer of the larynx: Phase Ib study

BACKGROUND: The purpose of this study was for us to report results regarding the safety of 3‐(1′‐hexyloxyethyl) pyropheophorbide‐a (HPPH) mediated photodynamic therapy (PDT) in early laryngeal disease, and offer preliminary information on treatment responses. METHODS: A single‐institution, phase Ib,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafirstein, Gal, Rigual, Nestor R., Arshad, Hassan, Cooper, Michele T., Bellnier, David A., Wilding, Gregory, Tan, Wei, Merzianu, Mihai, Henderson, Barbara W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499022/
https://www.ncbi.nlm.nih.gov/pubmed/25580824
http://dx.doi.org/10.1002/hed.24003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499022/
https://www.ncbi.nlm.nih.gov/pubmed/25580824
http://dx.doi.org/10.1002/hed.24003

Ejemplares similares